CT-guided radiofrequency ablation shows promise in kidney carcinoma:
This article was originally published in Clinica
CT-guided radiofrequency ablation (RFA) proved 100% successful in eradicating small malignant kidney tumours in a study by researchers from Wake Forest University Baptist Medical Center, in Winston-Salem, North Carolina. A total of 125 tumours, measuring 0.6 to 8.8cm, in 104 patients with renal cell carcinoma (RCC) were treated between 2000 and 2006. Of 95 tumours that were smaller than 3.7cm, all were completely eradicated by a single treatment. 21 of the 30 tumours larger than 3.7cm were also destroyed in the trial, giving a 93% overall success rate for large and small tumours. The findings appear in the August issue of The American Journal of Roentgenology.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.